News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
682,488 Results
Type
Article (39879)
Company Profile (265)
Press Release (642344)
Section
Business (204553)
Career Advice (1994)
Deals (35496)
Drug Delivery (80)
Drug Development (80860)
Employer Resources (167)
FDA (16018)
Job Trends (14825)
News (345091)
Policy (32525)
Tag
Academia (2586)
Africa (722)
Alliances (49447)
Alzheimer's disease (1138)
Approvals (15956)
Arizona (170)
Artificial intelligence (65)
Asia (37198)
Australia (6035)
Bankruptcy (352)
Best Places to Work (11269)
Biosimilars (63)
Biotechnology (187)
C2C Services and Suppliers (79253)
California (1663)
Canada (861)
Cancer (341)
Career advice (1661)
Cell therapy (103)
China (120)
Clinical research (63153)
Collaboration (115)
Colorado (65)
Compensation (61)
Connecticut (65)
COVID-19 (2500)
Cystic fibrosis (73)
Data (169)
Diabetes (70)
Diagnostics (6032)
Drug pricing (61)
Earnings (83761)
Employer resources (142)
Europe (79463)
Events (108113)
Executive appointments (112)
FDA (16202)
Florida (230)
Funding (108)
Gene therapy (80)
GLP-1 (510)
Government (4305)
Healthcare (18672)
Hotbed/Location (483117)
Illinois (240)
Indiana (136)
Infectious disease (2524)
Inflammatory bowel disease (87)
Interviews (307)
IPO (16239)
Job creations (3635)
Job search strategy (1425)
Kansas (94)
Layoffs (396)
Legal (7847)
Lung cancer (76)
Manufacturing (76)
Maryland (358)
Massachusetts (1376)
Medical device (13101)
Medtech (13104)
Mergers & acquisitions (19080)
Metabolic disorders (227)
Michigan (118)
Minnesota (207)
Neuroscience (1266)
New Jersey (501)
New York (518)
NextGen Class of 2024 (6523)
Non-profit (4482)
North Carolina (583)
Northern California (748)
Obesity (139)
Ohio (98)
Opinion (176)
Patents (63)
Pennsylvania (537)
People (56131)
Pharmaceutical (61)
Phase I (19599)
Phase II (27824)
Phase III (20780)
Pipeline (99)
Postmarket research (2548)
Preclinical (8344)
Press Release (65)
Rare diseases (117)
Real estate (5916)
Recruiting (63)
Regulatory (21237)
Research institute (2354)
Resumes & cover letters (348)
South America (1093)
Southern California (669)
Startups (3596)
Texas (201)
United States (7760)
Vaccines (455)
Washington State (237)
Weight loss (123)
Date
Last 7 days (581)
Last 30 days (2038)
Last 365 days (37370)
2024 (25154)
2023 (40282)
2022 (51396)
2021 (55958)
2020 (54336)
2019 (46807)
2018 (35246)
2017 (32380)
2016 (31774)
2015 (37825)
2014 (31526)
2013 (26591)
2012 (28789)
2011 (29426)
2010 (27538)
682,488 Results for "c2i genomics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Veracyte Completes Acquisition of C2i Genomics
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has completed its acquisition of C2i Genomics, Inc., adding whole-genome minimal residual disease (MRD) capabilities to its novel diagnostics platform.
February 6, 2024
·
5 min read
Business
Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform
Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform.
January 8, 2024
·
9 min read
Business
Dovetail Genomics and AGRF Announce Transformative Partnership Set to Advance Genomic Research in Australasia
Dovetail Genomics, a pioneering leader in the development of genomic solutions, announced a new strategic partnership with Australian Genome Research Facility.
June 24, 2024
·
4 min read
healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program
HUNTSVILLE, Ala., March 20, 2024 – healthŌme®, Inc., a leading genomics-based, precision health management company serving the life and critical illness industries, and GalenusRx, Inc.,
March 20, 2024
·
5 min read
Business
Children’s Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis
Children’s Mercy Kansas City, one of the leading independent pediatric health organizations, and Geneyx Inc. are pleased to announce a collaboration aimed at advancing genomic research and analysis.
March 13, 2024
·
4 min read
Reveal Genomics® HER2DX® Genomic Test Demonstrates Significant Potential in HER2-Positive Advanced Gastric Cancer
Reveal Genomics ® HER2DX ® Genomic Test Demonstrates Significant Potential in HER2-Positive Advanced Gastric Cancer.
June 27, 2024
·
5 min read
Press Releases
Moss Genomics Inc. Welcomes Martin Bajic to Its Board
July 19, 2024
·
2 min read
Business
SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers
SOHM, Inc. announces today the collaboration with Coastar Therapeutics, announce their collaboration to advance the field of genome editing using Coastar’s red blood cell membrane derived carriers and SOHM’s ABBIE (A Binding Based Integrase Enzyme) genome editing technology.
April 1, 2024
·
4 min read
Biotech Beach
Singular Genomics Announces 1-for-30 Reverse Stock Split
Singular Genomics Systems, Inc. announced that on June 26, 2024, effective at 12:01 a.m. Eastern Time, it will effectuate a 1-for-30 reverse split of its common stock.
June 21, 2024
·
5 min read
Business
Reveal Genomics® to Evaluate Prospective Real-time Performance of HER2DX® Genomic Test in the United States
Reveal Genomics® to Evaluate Prospective Real-time Performance of HER2DX ® Genomic Test in the United States.
June 18, 2024
·
4 min read
1 of 68,249
Next
